US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Invesco KBW Premium Yield Equity REIT ETF

17.15

-0.2100-1.21%

Post-market: 17.300.1547+0.90%19:35 EDT

Volume:230.96K

Turnover:3.97M

Market Cap:308.19M

PE:- -

High:17.29

Open:17.29

Low:17.13

Close:17.36

52wk High:19.35

52wk Low:14.82

Shares:17.97M

Float Shares:17.97M

Volume Ratio:1.27

T/O Rate:1.29%

Dividend:1.49

Dividend Rate:8.66%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

RenovoRx Highlights Peer-Reviewed Publication of Pharmacokinetic and Pharmacodynamic (PK/PD) Data Supporting TAMP™ Platform’s Targeted Drug-Delivery in Locally Advanced Pancreatic Cancer

Morgan Stanley Remains a Hold on Park Hotels & Resorts (PK)

Innovative Industrial Properties Lawsuit: IIPR Defendants Ask Court to Dismiss Investor Claims

Top Economist Guan Tao Joins Huafu Securities, Igniting a High-Stakes Research Rivalry Between Fujian's Two Brokerage Giants

Why Park Hotels & Resorts (PK) Is Up 6.6% After Returning To Profitability In Q2 2026

Simply Wall St.

US Treasury Expands Long-Dated Buyback Operations to at Least $4 Billion Per Auction Amid Yield Surge

NYSE Order Imbalance 36700.0 Shares on Buy Side

THOMSON REUTERS

Propanc Biopharma Clears Path for World-First Phase 1b Clinical Study of Breakthrough Cancer Therapy PRP

Goldman Sachs to buy LCN Capital Partners for up to $410M, Bloomberg reports

Huntington Adjusts PT on Gladstone Commercial to $13.50 From $13, Maintains Market Perform Rating

MT Newswires Live

Top Executive Makes Bold Move With Fresh Community Healthcare Stock Buy

Castle Securities Warns Fed's Inaction on Inflation Poses Growing Risk as Long-Term Treasury Yields Approach Two-Decade Highs

Community Healthcare Trust CEO David H. Dupuy Buys $151,300 Common Shares

Park Hotels & Resorts (PK) Returns To Profit, Is The 22% Undervalued View Still Compelling?

Simply Wall St.

NYSE Order Imbalance 30647.0 Shares on Sell Side

THOMSON REUTERS

Press Release: Yarrow Bioscience Reports Second Quarter 2026 Financial Results and Provides Business Update

Transforming Commercial Real Estate: The Shift from Standard Boxes to Unique Spatial Experiences

Community Healthcare Trust Director Robert Z. Hensley Acquires 8,000 Common Shares Worth $121,680

Gladstone Commercial Posts Investor Presentation Outlining Net-Lease Industrial Portfolio Strategy and Balance Sheet Profile

Press Release: Absci Reports Business Updates and Second Quarter 2026 Financial and Operating Results

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"Tiger Brokers,U.S. stock trading,Hong Kong stock trading,trading U.S. stocks,stock information,stock prices,U.S. stock quotes,U.S. stock trading,Hong Kong stock trading,IPO trading,buying U.S. stocks,global investment","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/stock/KBWY/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"KBWY","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KBWY\",,,,,undefined,":{"symbol":"KBWY","market":"US","secType":"STK","nameCN":"Invesco KBW Premium Yield Equity REIT ETF","latestPrice":17.15,"timestamp":1789761600000,"preClose":17.36,"halted":0,"volume":230963,"hourTrading":{"tag":"盘后","latestPrice":17.3047,"preClose":17.15,"latestTime":"19:35 EDT","volume":769,"amount":13284.2619,"timestamp":1789774501599,"change":0.1547,"changeRate":0.00902,"amplitude":0.00902},"delay":0,"changeRate":-0.012096774193548437,"floatShares":17970000,"shares":17970000,"eps":0,"marketStatus":"Market Closed","change":-0.21,"latestTime":"09-18 16:00:00 EDT","open":17.29,"high":17.29,"low":17.125,"amount":3968984.1354259998,"amplitude":0.009505,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1789977600000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":17.36,"sharesOutstanding":16420000,"nav":17.33882,"aum":331865014.8,"dividendRate":0.086601,"bidAskSpread":0.000577,"preHourTrading":{"tag":"盘前","latestPrice":17.27,"preClose":17.36,"latestTime":"09:29 EDT","volume":1255,"amount":21650.31122,"timestamp":1789738199999,"change":-0.09,"changeRate":-0.005184,"amplitude":0.035138},"postHourTrading":{"tag":"盘后","latestPrice":17.3047,"preClose":17.15,"latestTime":"19:35 EDT","volume":769,"amount":13284.2619,"timestamp":1789774501599,"change":0.1547,"changeRate":0.00902,"amplitude":0.00902},"volumeRatio":1.2657115857253411,"impliedVol":0,"impliedVolPercentile":0.008},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KBWY\",,,,,undefined,":{"symbol":"KBWY","floatShares":17970000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.2657115857253411,"shares":17970000,"dividePrice":1.4852,"high":17.29,"amplitude":0.009505,"preClose":17.36,"low":17.125,"week52Low":14.815,"pbRate":"--","week52High":19.35,"institutionHeld":0,"latestPrice":17.15,"eps":0,"divideRate":0.086601,"volume":230963,"delay":0,"ttmEps":0,"open":17.29,"prevYearClose":15.4324,"prevWeekClose":17.49,"prevMonthClose":17.8786,"prevQuarterClose":18.57,"fiveDayClose":17.49,"twentyDayClose":18.3176,"sixtyDayClose":18.1665},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/KBWY\",params:#limit:5,,,undefined,":[{"date":"2026-09-21","symbol":"KBWY","amount":0.11987,"announcedDate":"2026-09-18","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-09-21","defaultRemindTime":1789997400000,"name":"Invesco KBW Premium Yield Equity REIT ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-09-25","payableDate":"2026-09-21","currency":"USD","dateTimestamp":1789963200000,"payDate":"2026-09-25"},{"date":"2026-08-24","symbol":"KBWY","amount":0.1199,"announcedDate":"2026-08-21","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-08-24","defaultRemindTime":1787578200000,"name":"Invesco KBW Premium Yield Equity REIT ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-08-28","payableDate":"2026-08-24","currency":"USD","dateTimestamp":1787544000000,"payDate":"2026-08-28"},{"date":"2026-07-20","symbol":"KBWY","amount":0.11998,"announcedDate":"2026-07-17","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-07-20","defaultRemindTime":1784554200000,"name":"Invesco KBW Premium Yield Equity REIT ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-07-24","payableDate":"2026-07-20","currency":"USD","dateTimestamp":1784520000000,"payDate":"2026-07-24"},{"date":"2026-06-22","symbol":"KBWY","amount":0.12001,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-22","defaultRemindTime":1782135000000,"name":"Invesco KBW Premium Yield Equity REIT ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-26","payableDate":"2026-06-22","currency":"USD","dateTimestamp":1782100800000,"payDate":"2026-06-26"},{"date":"2026-05-18","symbol":"KBWY","amount":0.12252,"announcedDate":"2026-05-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-05-18","defaultRemindTime":1779111000000,"name":"Invesco KBW Premium Yield Equity REIT ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-05-22","payableDate":"2026-05-18","currency":"USD","dateTimestamp":1779076800000,"payDate":"2026-05-22"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"KBWY\",market:\"US\",,,undefined,":[{"executeDate":"2016-10-14","recordDate":"2016-10-18","paymentDate":"2016-10-31","value":0.27757,"currency":"USD"},{"executeDate":"2016-11-15","recordDate":"2016-11-17","paymentDate":"2016-11-30","value":0.22626,"currency":"USD"},{"executeDate":"2016-12-15","recordDate":"2016-12-19","paymentDate":"2016-12-30","value":0.22488,"currency":"USD"},{"executeDate":"2017-01-13","recordDate":"2017-01-18","paymentDate":"2017-01-31","value":0.21316,"currency":"USD"},{"executeDate":"2017-02-15","recordDate":"2017-02-17","paymentDate":"2017-02-28","value":0.20398,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"KBWY\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"KBWY\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2662732665","title":"RenovoRx Highlights Peer-Reviewed Publication of Pharmacokinetic and Pharmacodynamic (PK/PD) Data Supporting TAMP™ Platform’s Targeted Drug-Delivery in Locally Advanced Pancreatic Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2662732665","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662732665?lang=en_us&edition=fundamental","pubTime":"2026-08-25 20:30","pubTimestamp":1787661000,"startTime":"0","endTime":"0","summary":"PK/PD Data is from a Sub-Study in the Phase III TIGeR-PaC Clinical Trial The Study Shows Approximately 51% Tumor-Site Drug Extraction, Decreased Systemic Exposure, and Significant Correlation Between ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/25/3350436/0/en/renovorx-highlights-peer-reviewed-publication-of-pharmacokinetic-and-pharmacodynamic-pk-pd-data-supporting-tamp-platform-s-targeted-drug-delivery-in-locally-advanced-pancreatic-can.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1815336091.USD","IDNA","LU0274383776.USD","BK4539","LU2931357623.SGD","BK4017","LU1169589451.USD","IE00B66KJ199.SGD","BK4218","BK4023","IE0009354923.USD","LU0345780521.USD","LU0757428866.USD","GDOC","BK4181","LU1169590202.USD","LABU","IE00B7SZL793.SGD","IAG","KBWY","IE00B19Z4B17.USD","BK4157","IE0031619046.USD","NVIB","AEIS","ODD","PK","BK4585","PD","LU2089985449.USD","MEDX","BK4139","LU0345780281.USD","BK4183","BK4588","RNXT","HYLG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662473481","title":"Morgan Stanley Remains a Hold on Park Hotels & Resorts (PK)","url":"https://stock-news.laohu8.com/highlight/detail?id=2662473481","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662473481?lang=en_us&edition=fundamental","pubTime":"2026-08-25 19:55","pubTimestamp":1787658936,"startTime":"0","endTime":"0","summary":"In a report released today, Stephen Grambling from Morgan Stanley maintained a Hold rating on Park Hotels & Resorts, with a price target of $11.00....","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/morgan-stanley-remains-a-hold-on-park-hotels-resorts-pk-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/morgan-stanley-remains-a-hold-on-park-hotels-resorts-pk-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4218","BK4181","KBWY","PK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661297559","title":"Innovative Industrial Properties Lawsuit: IIPR Defendants Ask Court to Dismiss Investor Claims","url":"https://stock-news.laohu8.com/highlight/detail?id=2661297559","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661297559?lang=en_us&edition=fundamental","pubTime":"2026-08-22 03:35","pubTimestamp":1787340955,"startTime":"0","endTime":"0","summary":"Innovative Industrial Properties, Inc. (NYSE: IIPR) and several current or former executives have asked a federal court in Maryland to dismiss an i...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/class-action/innovative-industrial-properties-lawsuit-iipr-defendants-ask-court-to-dismiss-investor-claims?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/class-action/innovative-industrial-properties-lawsuit-iipr-defendants-ask-court-to-dismiss-investor-claims?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["KBWY","BK4224","IIPR","BK4171"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1117581770","title":"Top Economist Guan Tao Joins Huafu Securities, Igniting a High-Stakes Research Rivalry Between Fujian's Two Brokerage Giants","url":"https://stock-news.laohu8.com/highlight/detail?id=1117581770","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1117581770?lang=en_us&edition=fundamental","pubTime":"2026-08-21 18:10","pubTimestamp":1787307038,"startTime":"0","endTime":"0","summary":"A major personnel move has sent ripples through the securities industry as Guan Tao officially steps into the role of chief economist at Huafu Securities, a transition announced via the firm's...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KCE","BK4181","161027","PK","KBWY","BK4218"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660477144","title":"Why Park Hotels & Resorts (PK) Is Up 6.6% After Returning To Profitability In Q2 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2660477144","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660477144?lang=en_us&edition=fundamental","pubTime":"2026-08-20 09:32","pubTimestamp":1787189536,"startTime":"0","endTime":"0","summary":"In August 2026, Park Hotels & Resorts Inc. reported second-quarter 2026 results, with revenue of US$680 million and net income of US$47 million, marking a move from a net loss a year earlier.\nAn interesting shift is that both the quarter and the first half of 2026 showed positive earnings per share from continuing operations after losses in the prior-year periods, signaling a clear return to profitability.\nWith earnings swinging back to profit, we will now examine how this earnings...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/9621070-choice1-main-header/1585186786447","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9621070-choice1-main-header/1585186786447"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/real-estate/nyse-pk/park-hotels-resorts/news/why-park-hotels-resorts-pk-is-up-66-after-returning-to-profi","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/real-estate/nyse-pk/park-hotels-resorts/news/why-park-hotels-resorts-pk-is-up-66-after-returning-to-profi","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["KBWY","PK","BK4218","BK4181"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1153201297","title":"US Treasury Expands Long-Dated Buyback Operations to at Least $4 Billion Per Auction Amid Yield Surge","url":"https://stock-news.laohu8.com/highlight/detail?id=1153201297","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1153201297?lang=en_us&edition=fundamental","pubTime":"2026-08-19 21:30","pubTimestamp":1787146228,"startTime":"0","endTime":"0","summary":"The US Treasury has announced a significant expansion of its liquidity support buyback program for long-dated government bonds, a move widely interpreted by markets as a direct response to...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SHV","FDRR","LFAL","TBJL","IWB","SGOV","TLTM","DVUT","SHY","VUSG","BBSB","BNDD","IGOV","KBWY","LLDR","IBGL","FEAC","SWAN","NPFI","BSCW","IBGM","IBGK","PSK","IPPP","SCHQ","TLH","SPTL","BK4585","BWX","IEF","FLC","IRET","TTT","IBGC","DPRE","TLTI","TSYW","TFJL","TLTW","QTJA","IBTR","LFAO","DFP","MQQQ","BK4588","IBTQ","IBTP","IEI","ISHG","FLGV","TLTX","XLRI","EPRF","BBLB","BWZ","BBIB","LCF","TLT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660945054","title":"NYSE Order Imbalance 36700.0 Shares on Buy Side","url":"https://stock-news.laohu8.com/highlight/detail?id=2660945054","media":"THOMSON REUTERS","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660945054?lang=en_us&edition=fundamental","pubTime":"2026-08-19 03:50","pubTimestamp":1787082605,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nAQN2MFD68:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4171","BK4224","IIPR","KBWY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660467809","title":"Propanc Biopharma Clears Path for World-First Phase 1b Clinical Study of Breakthrough Cancer Therapy PRP","url":"https://stock-news.laohu8.com/highlight/detail?id=2660467809","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660467809?lang=en_us&edition=fundamental","pubTime":"2026-08-18 20:30","pubTimestamp":1787056200,"startTime":"0","endTime":"0","summary":"Avance Clinical to Lead Preparatory Activities for Multi-Center Investigation Across AustraliaMELBOURNE, Australia, Aug.  18, 2026 (GLOBE NEWSWIRE) -- Propanc Biopharma, Inc. (Nasdaq: PPCB) (“Propanc”","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/18/3346826/0/en/propanc-biopharma-clears-path-for-world-first-phase-1b-clinical-study-of-breakthrough-cancer-therapy-prp.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4218","IE00BYQQ9H92.USD","LU1169589451.USD","LU1169590202.USD","LU2413666699.HKD","BK4585","BK4533","IE00BFXG0V08.USD","LU1093756325.SGD","LU1093756168.USD","MTD","PD","LU2413666426.HKD","BK4567","BK4548","BK4181","PK","LU0347712357.USD","BK4023","KBWY","LU2211817866.USD","BK4121","LU1721428933.USD","IE00B5TLWC47.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660464927","title":"Goldman Sachs to buy LCN Capital Partners for up to $410M, Bloomberg reports","url":"https://stock-news.laohu8.com/highlight/detail?id=2660464927","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660464927?lang=en_us&edition=fundamental","pubTime":"2026-08-18 19:40","pubTimestamp":1787053221,"startTime":"0","endTime":"0","summary":"Goldman Sachs (GS) will pay as much as $410M to buy LCN Capital Partners, a commercial real estate investor, Bloomberg’s Todd Gillespie and Sridhar...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/goldman-sachs-to-buy-lcn-capital-partners-for-up-to-410m-bloomberg-reports-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/goldman-sachs-to-buy-lcn-capital-partners-for-up-to-410m-bloomberg-reports-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PFFR","MDIV","DFAR","ALTY","DFGR","FXO","GABF","IRET","PPTY","REIX","INKM","HYIN","GRI","CRED","BLDG","DFNL","GMOV","AVRE","CSRE","AREA","REET","IFGL","DESK","PFI","FTXO","GQRE","FPRO","IWN","INDS","JPRE","BBRE","NURE","KBWB","FLV","IWS","HIPS","ITAN","HAUZ","FREL","IQRA","JPO","KRE","KBWD","KBWY","JRE","PSCF","FRI","BYRE","IYRI","NETL","ICF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660465415","title":"Huntington Adjusts PT on Gladstone Commercial to $13.50 From $13, Maintains Market Perform Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2660465415","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660465415?lang=en_us&edition=fundamental","pubTime":"2026-08-18 17:33","pubTimestamp":1787045596,"startTime":"0","endTime":"0","summary":"Huntington Adjusts PT on Gladstone Commercial to $13.50 From $13, Maintains Market Perform Rating","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["KBWY","BK4160","GOOD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660456504","title":"Top Executive Makes Bold Move With Fresh Community Healthcare Stock Buy","url":"https://stock-news.laohu8.com/highlight/detail?id=2660456504","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660456504?lang=en_us&edition=fundamental","pubTime":"2026-08-18 10:06","pubTimestamp":1787018799,"startTime":"0","endTime":"0","summary":"New insider activity at Community Healthcare ( ($CHCT) ) has taken place on August 17, 2026. Community Healthcare has seen a notable insider move a...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/top-executive-makes-bold-move-with-fresh-community-healthcare-stock-buy-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/top-executive-makes-bold-move-with-fresh-community-healthcare-stock-buy-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","BK4585","XBI","CHCT","BK4203","BK4588","KBWY","XLV","BK4225","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1177297613","title":"Castle Securities Warns Fed's Inaction on Inflation Poses Growing Risk as Long-Term Treasury Yields Approach Two-Decade Highs","url":"https://stock-news.laohu8.com/highlight/detail?id=1177297613","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1177297613?lang=en_us&edition=fundamental","pubTime":"2026-08-18 06:41","pubTimestamp":1787006493,"startTime":"0","endTime":"0","summary":"Castle Securities believes the Federal Reserve's reluctance to tighten monetary policy further, despite inflation running above target for an extended period, is keeping long-term Treasury yields at...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KBWY","SPYQ","MESmain","HYG","SMAX","UDN","VOO","FLC","SPYI","BK4585","TYO","BWX","BBIB","EPRF","FLGV","SHV","BSCW","SPYB","FEM","TFJL","TMF","NPFI","TLTX","KRX","DVUT","MYCN","VEXC","SWAN","TBIL","BK4535","SPXL","SKRE","IGOV","HIBL","EMPB","VFH","BK4534","BK4561","SCHQ","DMAX","JPST","LIAJ","LFAL","SPDN","XLF","AGG","FDRR","IBTR","BK4581","PSK","VGLT","SCHO","SPUU","TTT","BIL","MUNX","XLRI","IBGM","LLDR","WAMA","IRET","LQD","PBDC","BNDD","TNmain","DPST","UBT","VGSH","MUB","BWZ","OEX","BK4504","KBWB","161027","VCSH","TLTM","BOND","ZROZ","ZTmain","BK4550","TBT","DFP","UBmain","TBJL","IWB","NEMD","SPTL","IBTQ","GOLY","UUP","KBE","OEF","BK4559","USHY","IBTP","VUSG","UPRO","TSYW","NELS","EDV","CIVG","SH","MQQQ","LCF","KRE",".SPX","TLTI","ZBmain","SPXU","SPXS","RAUS","SPYH","IEF","GBIL","BND","ZFmain","TLT","YSPY","OOQB","GOVT","MMAX","IBGC","MINT","IVV","IBGK","QTJA","BSV","SPYM","FAZ","IEI","TIP","LFAO","JULD","SPY","SGOV","IPPP","VGIT","IAT","FEAC","IBGL","ISHG","BK4588","NGHT","HMOP","XBIL","VCIT","EBUF","ESmain","SHY","BOXX","SPYU","TLTW","BBSB","SSO","BBLB","DBND","DPRE","TLH","SDS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660432810","title":"Community Healthcare Trust CEO David H. Dupuy Buys $151,300 Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2660432810","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660432810?lang=en_us&edition=fundamental","pubTime":"2026-08-18 04:16","pubTimestamp":1786997764,"startTime":"0","endTime":"0","summary":"Community Healthcare Trust CEO David H. Dupuy buys $151,300 common sharesCommunity Healthcare Trust CEO and President David H. Dupuy bought 10,000 common shares in an open-market purchase.Shares were ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nNDL41c1G9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Community Healthcare Trust CEO David H. Dupuy Buys $151,300 Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4225","BK4203","CHCT","KBWY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660102210","title":"Park Hotels & Resorts (PK) Returns To Profit, Is The 22% Undervalued View Still Compelling?","url":"https://stock-news.laohu8.com/highlight/detail?id=2660102210","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660102210?lang=en_us&edition=fundamental","pubTime":"2026-08-17 13:23","pubTimestamp":1786944228,"startTime":"0","endTime":"0","summary":"Park Hotels & Resorts earnings shift draws fresh investor focus\nPark Hotels & Resorts (PK) recently reported second quarter 2026 results that moved from a net loss to net income, with higher earnings per share. This earnings shift is now central to how investors assess the stock.\nSee our latest analysis for Park Hotels & Resorts.\nPark Hotels & Resorts’ recent earnings shift has come alongside strong momentum in the share price, with a 90 day share price return of 37.55% and a 1 year total...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/9621070-choice1-main-header/1585186786447","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9621070-choice1-main-header/1585186786447"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/real-estate/nyse-pk/park-hotels-resorts/news/park-hotels-resorts-pk-returns-to-profit-is-the-22-undervalu","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/real-estate/nyse-pk/park-hotels-resorts/news/park-hotels-resorts-pk-returns-to-profit-is-the-22-undervalu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["RGLO","DECU","JOYT","GXDW","KBWY","VOTE","BK4181","PK","BK4218","VGFPF","FEBU","PMDE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659644681","title":"NYSE Order Imbalance 30647.0 Shares on Sell Side","url":"https://stock-news.laohu8.com/highlight/detail?id=2659644681","media":"THOMSON REUTERS","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659644681?lang=en_us&edition=fundamental","pubTime":"2026-08-14 03:50","pubTimestamp":1786650603,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nAQN2MEJBX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4203","CHCT","BK4225","KBWY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659733155","title":"Press Release: Yarrow Bioscience Reports Second Quarter 2026 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2659733155","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659733155?lang=en_us&edition=fundamental","pubTime":"2026-08-13 19:00","pubTimestamp":1786618800,"startTime":"0","endTime":"0","summary":"--  The Company initiated the Phase 2a/2b trial of YB-101 in patients with. Graves' disease , with or without concurrent thyroid eye disease. --  The Phase 2a portion of the trial is a randomized,four cohorts designed to evaluate safety, pharmacokinetics ,pharmacodynamics , and efficacy over 24 weeks, including the. percentage of patients who are euthyroid and off anti-thyroid. drugs, as well as relevant measures of orbitopathy in patients. --  Topline results from the Phase 2a portion of the trial are. --  The Phase 2b portion of the trial is expected to commence in the. --  Licensing partner, Changchun GeneScience Pharmaceutical Co., Ltd.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","SHLD","BK4566","PD","BK4187","FOWF","PK","WDGF","GD","BK4550","TSHR","BK4588","PPA","BK4516","LU1169590202.USD","KBWY","BK4181","LU1169589451.USD","YB","BK4218","LU0170899867.USD","BK4023","IDEF","BK4173","BK4585","YARW"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1112583311","title":"Transforming Commercial Real Estate: The Shift from Standard Boxes to Unique Spatial Experiences","url":"https://stock-news.laohu8.com/highlight/detail?id=1112583311","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1112583311?lang=en_us&edition=fundamental","pubTime":"2026-08-13 16:22","pubTimestamp":1786609370,"startTime":"0","endTime":"0","summary":"At the 2026 Boao Real Estate Forum, held on August 13th at the Westin Resort in Hainan's Blue Bay Lucheng, Tian Weilong, Chairman of Jinlou Group, delivered a speech titled \"The Spatial Revolution...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TRUR","DPRE","ACVU","URE","VGSR","IRET","JRE","IYRI","RSPR","JPRE","BYRE","REAI","REIX","SRET","SRS","FREI","ERET","AVRE","KBWY","RINC","SRHR","GRI","DFGR","HIPS","BK4007","XLRI","GQRE","IQRA","RWO","PSR","DRW","FREL","BK4550","CRIB","BK4139","CSRE","DVRE","NRO","RNTY","HAUZ","LPRE","BLDG","FPRO","DFAR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659900629","title":"Community Healthcare Trust Director Robert Z. Hensley Acquires 8,000 Common Shares Worth $121,680","url":"https://stock-news.laohu8.com/highlight/detail?id=2659900629","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659900629?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:16","pubTimestamp":1786565805,"startTime":"0","endTime":"0","summary":"Community Healthcare Trust Director Robert Z. Hensley acquires 8,000 common shares worth $121,680Director Robert Z. Hensley bought 8,000 Community Healthcare Trust common shares at a weighted average ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nNDL11T5ct:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Community Healthcare Trust Director Robert Z. Hensley Acquires 8,000 Common Shares Worth $121,680","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CHCT","KBWY","BK4225","BK4203"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659015809","title":"Gladstone Commercial Posts Investor Presentation Outlining Net-Lease Industrial Portfolio Strategy and Balance Sheet Profile","url":"https://stock-news.laohu8.com/highlight/detail?id=2659015809","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659015809?lang=en_us&edition=fundamental","pubTime":"2026-08-13 00:51","pubTimestamp":1786553510,"startTime":"0","endTime":"0","summary":"Gladstone Commercial posts investor presentation outlining net-lease industrial portfolio strategy and balance sheet profileGladstone Commercial outlined an industrial-led portfolio strategy, with ind","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nNDLbcNpwG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4160","GOOD","KBWY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658948282","title":"Press Release: Absci Reports Business Updates and Second Quarter 2026 Financial and Operating Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2658948282","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658948282?lang=en_us&edition=fundamental","pubTime":"2026-08-12 04:05","pubTimestamp":1786478700,"startTime":"0","endTime":"0","summary":"Announced positive interim Phase 1 data from the HEADLINE trial of ABS-201Completed $100 million underwritten offering, including $40 million strategic investment from Eli Lilly & CompanyCash, cash equivalents, and marketable securities now sufficient to fund operations into the second half of 2028VANCOUVER, Wash. and NEW YORK, Aug. 11, 2026  -- Absci Corporation , a clinical-stage biopharmaceutical company advancing breakthrough therapeutics designed with generative AI, today reported financial and operating results for the quarter ended June 30, 2026.\"The positive Phase 1 interim data from our HEADLINE trial, combined with our strengthened balance sheet and advancing platform, position us well for what comes next,\" said Sean McClain, Founder and CEO. \"We are fast approaching defining moments for Absci, with interim proof-of-concept data for pattern hair loss later this year and our full 26-week readout in early 2027. These results have the potential to demonstrate ABS-201's regenerat","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4218","BK4121","BK4588","CHAT","TM","PK","VTHR","BK4555","ARTY","KBWY","BK4585","ABSI","03160","BK4181","QTOC","AGIX","AIPO","BK4539","BK4604","ARKG","BK4099"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":8,"pageCount":3,"totalSize":155,"code":"91000000","status":"200"}]}}